Joseph H. Capper

Joseph H. Capper discloses dealings in 4 companies, chiefly TELA Bio, Inc., Anika Therapeutics, Inc. and Mimedx Group, Inc. In total, 17 filings cover trades dated from 1 January 2023 to 17 September 2026.

No open-market sale appears; the market trades are 6 purchases worth €1.6M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 11 share grants. Since January 2026: 4 purchases and no sales on the market.

A typical purchase (the median) is worth €48k. Measured against the company's value, the median purchase equals 0.073% of market capitalisation, across 4 purchases where it is known. Of 6 purchases, 3 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The newest entry dates from 18 September 2026: an open-market purchase of €51k, in TELA Bio, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.